Transposagen Biopharmaceuticals, Inc.

New Filing
CIK: 0001537601·Biotechnology·DELAWARE·Filed: Jul 18, 2012
Total Offering

$1,275,000

Amount Sold

$355,000

Investors

7

First Sale

Jul 17, 2012

Offering Details

Type
Equity
Exemptions
Rule 506
Entity Type
Corporation
Year Incorporated
2011
Non-Accredited Investors
No

Related Persons

NameRole
Eric M. Ostertag
Joseph Ruiz

Company

Transposagen Biopharmaceuticals, Inc.

145 GRAHAM AVENUE

LEXINGTON, KY, 40506

859-428-8561

SEC Filing

0000911959-12-000022

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Transposagen Biopharmaceuticals, Inc. Form D Filing — $1,275,000 | FilingFlow